ClinConnect ClinConnect Logo
Search / Trial NCT06415812

Evolutionary Systems Therapy for Personality Pathology

Launched by TAGES ONLUS · May 14, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Compassion Metacognition Personality Disorder Personality Pathology Evolutionary Psychopathology

ClinConnect Summary

This clinical trial is studying a new type of therapy called Evolutionary Systems Therapy, aimed at helping people with personality disorders. This therapy has been tested before, but this trial will explore how well it works for different types of personality disorders in both adolescents and young adults. The goal is to see if this therapy can be a helpful option for people struggling with these conditions.

To participate in the trial, you need to be diagnosed with a personality disorder and be able to read and sign a consent form. However, individuals with certain conditions, like schizophrenia, bipolar disorder, or autism, won't be eligible. If you join the study, you can expect to engage in therapy sessions and provide feedback about your experiences. The trial is currently recruiting participants of all genders, between the ages of 18 and 65. This could be an opportunity to try a new treatment to help manage personality disorders.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Being diagnosed with personality pathology in accordance with Structured Clinical Interview for DSM-5 - Alternative Model of Personality Disorders Module I
  • Being capable of read and sign the inform consent form
  • Exclusion Criteria:
  • Being diagnosed with schizophrenia spectrum disorders and other psychosis
  • Being diagnosed with bipolar disorders
  • Being diagnosed with autism spectrum disorder
  • Being diagnosed with intellectual disability
  • Being under any psychopharmacological or psychosocial treatment

About Tages Onlus

Tages Onlus is a prominent non-profit organization dedicated to advancing research and clinical trials in the field of rare diseases, particularly those affecting pediatric populations. With a strong commitment to improving patient outcomes, Tages Onlus collaborates with healthcare professionals, academic institutions, and industry partners to foster innovative therapeutic solutions. By focusing on patient-centered approaches and leveraging cutting-edge methodologies, the organization aims to enhance the understanding and treatment of complex medical conditions, ultimately striving to ensure that every affected individual has access to the best possible care and support.

Locations

Firenze, Fi, Italy

Patients applied

0 patients applied

Trial Officials

Simone Cheli, PhD

Principal Investigator

Tages Onlus

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported